Javascript must be enabled to continue!
The Regulatory Role of Endothelial CXCR4 in Cardiac Function
View through CrossRef
CXCR-4 is an alpha-chemokine receptor specific for stromal-derived factor-1 (SDF-1, also called CXCL12), a molecule endowed with potent chemotactic activity for lymphocytes. CXCR4 and CXCL12 signaling pathways are important for stem cell homing in myocardial ischemia and cardiovascular regeneration. Endothelial cells are a key player in maintaining vascular homeostasis. The global CXCR knockout mice are lethal, suggesting the essential role of the CXCL12 and CXCR4 signaling pathways in cardiovascular diseases. However, the role of CXCR4 in endothelial cells in vascular function and ischemic heart diseases is unknown. In this study, we use genetically modified mice (CXCR4 endothelial cell-specific knockout) to study the role of CXCR4 in endothelial cells in cardiovascular diseases such as diabetes. We have two groups of mice, the Cxcr4 floxed mice (Control mice), Cxcr4 floxed-Cadh5-cre mice (CXCR4 endothelial cell-specific knockout). Both groups of mice were fed on a chow or high fat and high sugar (HFHS) diet for six months. We performed echocardiography at different time points. The mice were under anesthesia with 2-3% isoflurane, and cardiac function was measured with B or M-mode and tissue Doppler. Then, the files were exported to a computer installed with the Vevo software. 3-5 measurements from different frames of images of each mouse for cardiac function systolic and diastolic cardiac function. Our preliminary data showed that 1) mice fed with a fat and high-sugar diet for six months developed diabetes with high plasma glucose levels and insulin resistance. 2) The cardiac function of mice on the HFHS diet was worse than that of the mice on the chow diet. 3) Knockout CXCR4 in endothelial cells caused cardiovascular dysfunction. It suggested that CXCR4/CXCL12 signaling pathway could be a potential target for developing a treatment for ischemic heart diseases.
AHA
This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
Title: The Regulatory Role of Endothelial CXCR4 in Cardiac Function
Description:
CXCR-4 is an alpha-chemokine receptor specific for stromal-derived factor-1 (SDF-1, also called CXCL12), a molecule endowed with potent chemotactic activity for lymphocytes.
CXCR4 and CXCL12 signaling pathways are important for stem cell homing in myocardial ischemia and cardiovascular regeneration.
Endothelial cells are a key player in maintaining vascular homeostasis.
The global CXCR knockout mice are lethal, suggesting the essential role of the CXCL12 and CXCR4 signaling pathways in cardiovascular diseases.
However, the role of CXCR4 in endothelial cells in vascular function and ischemic heart diseases is unknown.
In this study, we use genetically modified mice (CXCR4 endothelial cell-specific knockout) to study the role of CXCR4 in endothelial cells in cardiovascular diseases such as diabetes.
We have two groups of mice, the Cxcr4 floxed mice (Control mice), Cxcr4 floxed-Cadh5-cre mice (CXCR4 endothelial cell-specific knockout).
Both groups of mice were fed on a chow or high fat and high sugar (HFHS) diet for six months.
We performed echocardiography at different time points.
The mice were under anesthesia with 2-3% isoflurane, and cardiac function was measured with B or M-mode and tissue Doppler.
Then, the files were exported to a computer installed with the Vevo software.
3-5 measurements from different frames of images of each mouse for cardiac function systolic and diastolic cardiac function.
Our preliminary data showed that 1) mice fed with a fat and high-sugar diet for six months developed diabetes with high plasma glucose levels and insulin resistance.
2) The cardiac function of mice on the HFHS diet was worse than that of the mice on the chow diet.
3) Knockout CXCR4 in endothelial cells caused cardiovascular dysfunction.
It suggested that CXCR4/CXCL12 signaling pathway could be a potential target for developing a treatment for ischemic heart diseases.
AHA
This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format.
There is no downloadable file or PDF version.
The Physiology editorial board was not involved in the peer review process.
Related Results
CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis
CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis
AbstractBackgroundMammary tumours frequently develop in female domestic cats being highly malignant in a large percentage of cases. Chemokines regulate many physiological and patho...
Abstract 4117: AMD070, a novel orally bioavailable CXCR4 inhibitor, inhibits the metastases of oral cancer via SDF-1/CXCR4 system
Abstract 4117: AMD070, a novel orally bioavailable CXCR4 inhibitor, inhibits the metastases of oral cancer via SDF-1/CXCR4 system
Abstract
We have demonstrated that the stromal cell-derived factor (SDF)-1/CXCR4 system is involved in metastatic processes in oral cancer. Moreover, we have also re...
CXCR4 Inhibition as a Therapeutic Strategy in Leukemia.
CXCR4 Inhibition as a Therapeutic Strategy in Leukemia.
Abstract
The chemokine receptor CXCR4 is critically involved in the migration of hematopoietic cells to the stroma derived factor (SDF-1α)-producing bone marrow micr...
Abstract B8: Targeting CXCR4/CXCL12 axis by AMD3100 inhibits ECTC-associated metastasis in hepatocellular carcinoma.
Abstract B8: Targeting CXCR4/CXCL12 axis by AMD3100 inhibits ECTC-associated metastasis in hepatocellular carcinoma.
Abstract
Background: Hepatocellular carcinoma (HCC) is characterized by high incidence of blood-borne metastasis. We have recently found that endothelium-coated tumo...
Demethylation in promoter region of severely damaged hepatocytes enhances chemokine receptor CXCR4 gene expression
Demethylation in promoter region of severely damaged hepatocytes enhances chemokine receptor CXCR4 gene expression
Abstract
The liver is known to possess remarkable regenerative potential, but persistent inflammation or severe acute injury can lead to liver fibrosis and incomplete regen...
Abstract 1801: ERK-mediated regulation of NFAT3 enhances CXCR4 expression in HeyA8 ovarian cell line.
Abstract 1801: ERK-mediated regulation of NFAT3 enhances CXCR4 expression in HeyA8 ovarian cell line.
Abstract
The G-protein coupled chemokine (C-X-C motif) receptor CXCR4 is linked to cancer, HIV, and WHIM (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis...
Abstract 1592: CXCR4 pathways in CTCs: from bioinformatics to immunophenotype
Abstract 1592: CXCR4 pathways in CTCs: from bioinformatics to immunophenotype
Abstract
Introduction: Bioinformatics’ analysis regarding gene expression in Normal tissue vs cancer tissue, Normal blood vs cancer patients’ blood and Normal blood ...
DFO and DMOG up-regulate the expression of CXCR4 in bone marrow mesenchymal stromal cells
DFO and DMOG up-regulate the expression of CXCR4 in bone marrow mesenchymal stromal cells
The C-X-C chemokine receptor 4 (CXCR4) is a receptor of the chemokine stromal cell-derived factor 1. CXCR4/stromal cell-derived factor 1 is essential to the migration of cells. Up-...

